Olay Total Effects Pore Minimizing CCBroadspectrum SPF 15 Light to Medium (Procter & Gamble Manufacturing Company)
Welcome to the PulseAid listing for the Olay Total Effects Pore Minimizing CC drug offered from Procter & Gamble Manufacturing Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Procter & Gamble Manufacturing Company |
NON-PROPRIETARY NAME: | Homosalate, Octisalate, and Octocrylene |
SUBSTANCE NAME: | HOMOSALATE; OCTISALATE; OCTOCRYLENE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2014-05-01 |
END MARKETING DATE: | 0000-00-00 |
Olay Total Effects Pore Minimizing CC Broadspectrum SPF 15 Light to Medium HUMAN OTC DRUG Details:
Item Description | Olay Total Effects Pore Minimizing CC Broadspectrum SPF 15 Light to Medium from Procter & Gamble Manufacturing Company |
LABELER NAME: | Procter & Gamble Manufacturing Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4; 4.5; 2.6(g/100mL; g/100mL; g/100mL) |
START MARKETING DATE: | 2014-05-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 37000-319_93da35c0-9175-4ea3-8a04-b56fc1b76414 |
PRODUCT NDC: | 37000-319 |
APPLICATION NUMBER: | part352 |
Other HOMOSALATE; OCTISALATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers: